Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
TD-60 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
TD-60 Required for completion of mitosis and cytokinesis. May function as a guanine nucleotide exchange factor for the small GTPase RAC1. Binds preferentially to the nucleotide-free form of RAC1. Interacts with microtubules. Note: This description may include information from UniProtKB.
Protein type: Guanine nucleotide exchange factor, misc.
Cellular Component: microtubule; nucleolus; spindle; cytosol; chromosome, pericentric region
Biological Process: M phase of mitotic cell cycle; cell division; mitotic cell cycle; mitotic prometaphase
Reference #:  Q9P258 (UniProtKB)
Alt. Names/Synonyms: DKFZp762N0610; KIAA1470; Protein RCC2; RCC1-like protein TD-60; RCC2; regulator of chromosome condensation 2; TD-60; TD60; Telophase disk protein of 60 kDa
Gene Symbols: RCC2
Molecular weight: 56,085 Da
Basal Isoelectric point: 9.02  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

TD-60

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  DISEASE  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 S16-p AAWEEPSsGNGtARA
0 9 T20-p EPSsGNGtARAGPRk
0 1 K27-u tARAGPRkRGGPAGR
0 4 S43-p RERPERCssssGGGs
0 3 S44-p ERPERCssssGGGss
0 4 S45-p RPERCssssGGGssG
0 5 S46-p PERCssssGGGssGD
0 13 S50-p ssssGGGssGDEDGL
0 14 S51-p sssGGGssGDEDGLE
0 1 T74-p KRAARPAtAGKAGGA
0 1 T91-p VITEPEHtkERVKLE
0 1 K92-a ITEPEHtkERVKLEG
0 1 K92-u ITEPEHtkERVKLEG
0 1 K170-u LLITTEGkLWSWGRN
0 1 K179-u WSWGRNEkGQLGHGD
0 19 Y276-p MDCKGNLysFGCPEy
0 1 S277-p DCKGNLysFGCPEyG
0 16 Y283-p ysFGCPEyGQLGHNs
0 23 S290-p yGQLGHNsDGkFIAR
0 15 K293-a LGHNsDGkFIARAQR
0 6 K320-u AIFIEKTkDGQILPV
0 1 T342-p VACGANHtLVLDsQk
0 2 S347-p NHtLVLDsQkRVFSW
0 6 K349-a tLVLDsQkRVFSWGF
0 1 K349-u tLVLDsQkRVFSWGF
0 12 Y359-p FSWGFGGyGRLGHAE
0 2 K368-u RLGHAEQkDEMVPRL
0 6 K377-a EMVPRLVkLFDFPGR
0 10 K377-u EMVPRLVkLFDFPGR
0 1 T473-p DHKPKSStAAQEVkT
0 6 K479-u StAAQEVkTLDGIFS
  mouse

 
S14 AAWEEPSSGNGTARA
T18 EPSSGNGTARAGPRR
R25 TARAGPRRRGGPAGR
S41-p RERPERCssssGGGs
S42-p ERPERCssssGGGss
S43-p RPERCssssGGGssG
S44-p PERCssssGGGssGD
S48-p ssssGGGssGDEDGP
S49-p sssGGGssGDEDGPE
T72 KRTARPATAGKAAGA
T89 IITEPEHTKERVKLE
K90 ITEPEHTKERVKLEG
K90 ITEPEHTKERVKLEG
K168 LLITTEGKLWSWGRN
K177 WSWGRNEKGQLGHGD
Y274 MDCKGNLYSFGCPEY
S275 DCKGNLYSFGCPEYG
Y281 YSFGCPEYGQLGHNS
S288 YGQLGHNSDGKFIAR
K291 LGHNSDGKFIARAQR
K318 AIFIEKTKDGQILPV
T340 VACGANHTLVLDSQK
S345 NHTLVLDSQKRVFSW
K347 TLVLDSQKRVFSWGF
K347 TLVLDSQKRVFSWGF
Y357-p FSWGFGGyGRLGHAE
K366 RLGHAEQKDEMVPRL
K375 EMVPRLVKLFDFPGR
K375 EMVPRLVKLFDFPGR
T471 DHKPKSSTAAQEVKT
K477 STAAQEVKTLDGIFS
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.